Activation of p53 protein in normal and in tumor cells by a novel anticancer agent CHS 828. [electronic resource]
- Drugs under experimental and clinical research 2003
- 53-67 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0378-6501
Animals Antineoplastic Agents--pharmacology Apoptosis--drug effects Cell Division--drug effects Cell Line, Tumor Cells, Cultured Cyanides--pharmacology DNA--biosynthesis Dose-Response Relationship, Drug Drug Resistance, Multiple Drug Resistance, Neoplasm Fibroblasts--cytology Guanidines--pharmacology Humans Immunoblotting Mice Phosphorylation Poly Adenosine Diphosphate Ribose--deficiency Tumor Suppressor Protein p53--biosynthesis Up-Regulation